🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. Brigatinib

    Takeda

    Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma

    phase 2 small molecule terminated

    1 trial

  2. Brigatinib

    Takeda

    Anaplastic Large Cell Lymphoma, ALK-Positive

    phase 2 small molecule active

    1 trial

  3. Brigatinib

    Takeda

    ALK-positive Advanced NSCLC

    phase 2 small molecule completed

    2 trials

  4. C1 Esterase Inhibitor Injection [Cinryze]

    Takeda

    Subarachnoid Hemorrhage, Aneurysmal

    phase 2 small molecule active

    1 trial

  5. C1 Inhibitor, Human

    Takeda

    Traumatic Brain Injury

    phase 2 small molecule active

    1 trial

  6. CINRYZE

    Takeda

    Hereditary Angioedema

    phase 2 mab completed

    1 trial

  7. CINRYZE

    Takeda

    Hereditary Angioedema (HAE)

    phase 2 mab completed

    1 trial

  8. CINRYZE with rHuPH20

    Takeda

    Hereditary Angioedema (HAE)

    phase 2 mab completed

    1 trial

  9. CISPLATIN, CARBOPLATIN, KEYTRUDA 25 mg/mL concentrate for solution for infusion, CISPLATIN, FLUOROURACIL

    Takeda

    Solid Neoplasm

    phase 2 small molecule active

    1 trial

  10. CUVITRU - Ig subcutaneous human 20%

    Takeda

    COPD Exacerbation Acute

    phase 2 mab active

    1 trial

  11. CX501

    Takeda

    EPIDERMOLYSIS BULLOSA

    phase 2 small molecule completed

    1 trial

  12. Cabozantinib

    Takeda

    Advanced Renal Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  13. Cabozantinib

    Takeda

    Advanced Hepatocellular Carcinoma

    phase 2 small molecule completed

    1 trial

  14. Celaderm (Frozen Cultured Epidermal Allograft)

    Takeda

    Leg Ulcer

    phase 2 other completed

    1 trial

  15. Clarithromycin

    Takeda

    Myeloma

    phase 2 small molecule active

    1 trial

  16. Colchicine, 0.6 mg PO BID

    Takeda

    Atrial Fibrillation

    phase 2 small molecule completed

    1 trial

  17. Cx611

    Takeda

    Bacterial Pneumonia

    phase 2 mab completed

    1 trial

  18. Cyclophosphamide

    Takeda

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  19. Cyclophosphamide

    Takeda

    B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

    phase 2 small molecule active

    1 trial

  20. DEXLANSOPRAZOLE PEDIATRIC, DEXLANSOPRAZOLE PEDIATRIC, DEXLANSOPRAZOLE PEDIATRIC

    Takeda

    Erosive Esophagitis

    phase 2 small molecule active

    1 trial

  21. DEXLANSOPRAZOLE PEDIATRIC, DEXLANSOPRAZOLE PEDIATRIC, DEXLANSOPRAZOLE PEDIATRIC

    Takeda

    Symptomatic nonerosive GERD in paediatric subjects aged 2 to 11 years

    phase 2 small molecule active

    1 trial

  22. DX-88 (ecallantide)

    Takeda

    Hereditary Angioedema (HAE)

    phase 2 small molecule completed

    1 trial

  23. Danavorexton

    Takeda

    Sleep Apnea

    phase 2 small molecule completed

    2 trials

  24. Daratumumab, Ixazomib, Dexamethasone

    Takeda

    Multiple Myeloma

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources